Cargando…
Computational Breakthrough of Natural Lead Hits from the Genus of Arisaema against Human Respiratory Syncytial Virus
BACKGROUND: To date, efforts for the prevention and treatment of human respiratory syncytial virus (RSV) infection have been still vain, and there is no safe and effective clinical accepted vaccine. Arisaema genus has claimed for various traditional bioactivities, but scientific assessments are quit...
Autores principales: | Kant, Kamal, Lal, Uma Ranjan, Ghosh, Manik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822500/ https://www.ncbi.nlm.nih.gov/pubmed/29491633 http://dx.doi.org/10.4103/pm.pm_459_16 |
Ejemplares similares
-
In silico Prediction and Wet Lab Validation of Arisaema tortuosum (Wall.) Schott Extracts as Antioxidant and Anti-breast Cancer Source: A Comparative Study
por: Kant, Kamal, et al.
Publicado: (2017) -
The genus Arisaema : a monograph for botanists and nature lovers /
por: Gusman, Guy
Publicado: (2002) -
Poisoning due to Arisaema triphyllum Ingestion
por: Jadhav, Dhiraj Ramdas, et al.
Publicado: (2019) -
Sequencing and phylogenetic analysis of the complete chloroplast genome of Arisaema heterophyllum Blume
por: Yi, Shanyong, et al.
Publicado: (2021) -
Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants – Importance of design
por: Zhaori, Getu
Publicado: (2023)